CLSD News

The shortened holiday week saw three healthcare IPOs raise over $150 million, bringing the year-to-date total up to 34 offerings. Can't stop Nant: NantHealth surges 33% in year's second-best IPO debut Billionaire founder and CEO Patrick Soon-Shiong became even richer, as NantHealth (NH) raised $91 million and popped 33% on its debut....read more

Clearside Biomedical, which is developing a combination drug-device therapy for eye diseases, raised $50 million by offering 7.2 million shares at $7, as expected. The company revised the terms of the deal on Wednesday; it originally planned to raise $60 million by offering 4.0 million shares at a range of $14-16. Clearside Biomedical plans to list on the Nasdaq under the symbol...read more

Clearside Biomedical, which is developing a combination drug-device therapy for eye diseases, lowered the proposed deal size for its upcoming IPO on Wednesday. The Alpharetta, GA-based company now plans to raise $50 million by offering 7.2 million shares at a price of $7. Insiders intend to purchase $25 million (50%) worth of shares in the offering. The company had previously...read more

The year's most active week by deal count and proceeds is set to cap off the year's busiest month: The six scheduled IPOs would bring May's IPO count up to 16, making it the busiest month since...read more